Andy Monnich serves as Executive Vice President and Chief Corporate Development Officer at National Research Corporation (NRC), a leading provider of data-driven solutions for healthcare performance improvement. In this pivotal role, he spearheads the company's corporate development efforts, including mergers and acquisitions, strategic partnerships, joint ventures, and initiatives to drive organic and inorganic growth. Monnich plays a key role in identifying opportunities that align with NRC's mission to empower healthcare organizations with actionable insights for enhancing patient experience and operational efficiency. With over 25 years of experience in investment banking, healthcare services, and strategic advisory, Monnich joined NRC in 2013 from Robert W. Baird & Co., where he was a Managing Director in the Healthcare Investment Banking group. There, he advised on more than $20 billion in transactions, including M&A deals, capital raises, and divestitures for healthcare providers, payers, and technology firms. Earlier in his career, he held senior positions at Deloitte Consulting and L.E.K. Consulting, focusing on healthcare strategy and corporate finance. Monnich's achievements include orchestrating transformative acquisitions at NRC, such as the integration of complementary analytics platforms that expanded the company's market share and revenue streams. His strategic vision has been instrumental in positioning NRC as an innovator in healthcare analytics, earning recognition for deals that delivered strong shareholder value and advanced patient-centered care solutions. A graduate of the University of Notre Dame with an MBA from the University of Chicago Booth School of Business, Monnich is a respected thought leader in healthcare investment and development.